Top Markets
Coin of the day
Destiny Pharma plc Destiny Pharma plc

Destiny Pharma plc

DEST
Kedudukan dalam Saham #41142
Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in... Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in 1996, specializing in the identification, progression, and market introduction of pharmaceutical solutions for infectious diseases. The company's clinical pipeline includes NTCD-M3, currently in Phase III trials to prevent recurring Clostridioides difficile infections. Its XF-73 program features XF-73 Nasal, undergoing Phase II development for the prevention of post-surgical staphylococcal infections, and XF-73 Dermal, which is in Phase I for treating bacterial skin infections resistant to antibiotics. Additionally, Destiny Pharma's preclinical efforts involve SPOR-COV, a biotherapeutic product aimed at preventing COVID-19 and other viral respiratory diseases, and XF Drugs Biofilm, targeting antibiotic-resistant biofilm and bacterial aggregate infections. The company is also investigating further applications of its XF drugs for respiratory, oral mucosa, and ocular infections. Destiny Pharma maintains strategic alliances with various organizations, including China Medical System Holdings Limited, SporeGen Limited, the University of Southampton, Aston University, the University of Sheffield, Cardiff University, and Tianjin Medical University.
Harga Saham
$0.04082105
Disegerakkan terakhir: 2024-08-12
Modal Pasaran
$39.09K
Perubahan (1 hari)
-19.83%
Perubahan (1 tahun)
0.00%
Negara
GB
Perdagangan Destiny Pharma plc (DEST)

Kategori

Pendapatan untuk Destiny Pharma plc (DEST)
Pendapatan pada Dec 2023 TTM: $-8.21M
Menurut laporan kewangan terkini Destiny Pharma plc, pendapatan semasa syarikat ialah $-8.21M. Pada tahun 2022, syarikat memperoleh pendapatan sebanyak $-9.33M, penurunan berbanding pendapatan pada tahun 2021 yang berjumlah $-8.48M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Destiny Pharma plc dari 2013 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
2026 (TTM) $-8.21M 0.00%
2023 $-8.21M -12.04%
2022 $-9.33M 10.03%
2021 $-8.48M -4.31%
2020 $-8.86M 21.02%
2019 $-7.32M -4.32%
2018 $-7.65M 76.32%
2017 $-4.34M 142.61%
2016 $-1.79M 1.42%
2015 $-1.76M -45.18%
2014 $-3.22M 174.64%
2013 $-1.17M 0.00%
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
$5.27B -64,380.54%
US
$1.95B -23,870.85%
NL
- -
CH
- -
KR
$3.01B -36,728.02%
BE